The Centers for Medicare and Medicaid Services (CMS) has approved the implants for New Technology Add-on Payment (NTAP).
In addition to the on-label designation, the FDA has also granted a Breakthrough Device Designation (BDD) for this indication across the entirety of icotec's BlackArmor® spinal stabilization ...
FDA clearance for the use of BlackArmor implants in the treatment of de novo spinal infections. icotec is honoured to be the first and only company in the United States with FDA 510(k) clearance for ...
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.